GLOBAL CONCERNS ABOUT HPV VACCINES

FACT SHEET
• When detected, HPV infection is easily managed and rarely proceeds to cancer
• Very few women with HPV develop cervical cancer
• HPV infections are only one of several risk factors for cervical cancer
• At least 50% of sexually active men and women acquire genital HPV infection at some point in
their lives — 90% of the time the virus clears up on its own within two years without incident
• Centers for Disease Control and Prevention (CDC) records show 3,976 women died from cervical
cancer in the U.S. in 2006.
• American Cancer Society lists cervical cancer as the 12th leading cause of carcinoma related
deaths
• HPV Vaccine efficacy duration is at the maximum 5 to 6 years. Symptoms of girls adversely
injured are lasting as long as the vaccine.
• Non cancerous types of HPV: 6 & 11
• Cancerous types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 69, 73, 82
• Pap testing has reduced cervical cancer risk by 74% over the last 40 years

HPV VACCINE VAERS REPORTS

for full pdf report see here